[ad_1]
The AstraZeneca Group agreed on Friday that Brussels would publish the contract on the pre-order of the covid-19 vaccine, a document of about 40 pages published on the censored website of the European Commission (EC) – including full pages – “by confidentiality reasons. “.
Der Spiegel then revealed that a first version of the contract with AstraZeneca published online by the EC allowed the censored part of the document to be read using the “bookmark” function of the Acrobat PDF reader.
According to the text revealed by Der Spiegel, the bill for 300 million AstraZeneca / Oxford covid-19 vaccines is 870 million euros.
This amount includes all direct and indirect costs and expenses of the British laboratory for the production and distribution of the vaccine.
These include, for example, labor costs, materials, operation of facilities and equipment, quality control, non-deductible indirect taxes or customs duties.
Also according to Der Spiegel, the contract states that AstraZeneca will not incur losses due to the development of the vaccine.
If the costs exceed the estimated 870 million euros, the laboratory will inform the EC. If the excess is greater than 20%, the laboratory is obliged to accredit it.
The German magazine also reveals some pages on how to pay.
“The Commission undertakes to pay 336 million euros, of which two thirds will be paid within the five days following the entry into force of the contract on August 27, 2020. It is excluded, however, that the last third will be pay 20 days later AstraZeneca demonstrated the use of the first tranche ”, says the document.
The contract also provides for the possibility, not used until now, to request an additional 100 million doses of vaccine.
But the magazine does not reveal any details about the number of doses of the covid-19 vaccine that AstraZeneca will deliver to the EU.
Coincidentally, this data cannot be read with the “document markup” feature, the magazine claims.
The EU is putting a lot of pressure on AstraZeneca due to a significant delay in deliveries.
The group said it would deliver just 31 million doses by the end of March, instead of 80 million doses of the covid-19 vaccine, as originally planned.
The laboratory states that it is not contractually bound to deliver certain quantities of vaccine on specific dates.
The European Commission (EC) flatly denies this and accuses the laboratory of selling its covid-19 vaccine production with priority to the United Kingdom, to the detriment of the 27 Member States of the Union.
